PL EN


2012 | 4 | 566-572
Article title

The kinetics of bacterial growth in selected proand synbiotics – recommendations for family practitioner

Content
Title variants
Languages of publication
EN
Abstracts
Contributors
References
  • Hooper LV, Wong M, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine.Science 2001; 291: 881–884.
  • Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004; 4: 478–485.
  • Ohashi Y, Ushida K. Healt-beneficial effects of probiotics: Its mode of action. Anim Sci J 2009; 80: 361–371.
  • Surawicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii:a prospective study. Gastroenterology 1989; 96(4): 981–988.
  • Lee YK, Salminen S. The coming age of probiotics. Trends Food Sci Technol 1995; 6: 241–245.
  • Gibson GR, Probert HM, Loo JV, et al. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004; 17: 259–275
  • Roberfroid MB. Prebiotics and probiotics: are they functional foods? Am J Clin Nutr 2001; 71: 1682–1687.
  • Kumar M, Behare PV, Mohania D, et al. Health-promoting probiotic functional foods: potential and prospects. Agro Food Industry Hi-tech 2009; 20: 29–33.
  • Mack DR, Michail S, Wei S. Probiotics inhibit gastropatogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Amer J Phisiol 1999; 276: 941–950.
  • Van Niel C, Feudtner C, Garrison MM, et al. Lactobacillus therapy for acute infectious diarrhea in children: a metaanalysis.Pediatrics 2002; 109: 678–684.
  • Pothoulakis C, Kelly CP, Joshi MA. Sacharomyces boulardii inhibits Clostridium difficile toxin A blinding and enterotoxicity in rat ileum. Gastroenterology 1993; 104: 1108–1115.
  • Perdigon G, De Macias MEN, Alvarez S. Effect of perorally administred lactobacilli on macrophage activation in mice. Infect Immun 1986; 53: 404–410.
  • Marteau PR, de Vrese M, Cellier CJ, et al. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001; 73(Suppl.): 430–436.
  • Borritello SP, Hammes WP, Holzapfel W. Safety of probiotics that contain lactobacilli or bofidobacteria. Clin Infect Dis 2003; 36: 775–780.
  • D’Souza AL, Rajkumar C, Cooke J, et al. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. Br Med J 2002; 324: 1361–1364
  • De Simone C. The role of probiotics in modulation of the immune system in man and in animals. Int J Immunother 1993; 1: 23–28.
  • Bari ML, Isshiki K, Sabina Y, et al. Microbial Ecology of Spoilage. In: Ukuku D, Imam S, Lamikanra O, ed. Produce Degradation Pathways and Prevention. CRC Press; 2005: 379–419.
  • Paulton RJL. The Bacterial Growth Curve. J Biol Educ 1991; 25: 92–93.
  • Wintermute EH, Silver PA. Dynamics in the mixed. Genes & Dev 2010; 24: 2603–2614.
  • Kolida S, Tuohy K, Gibson GR. Prebiotic effects of inulin and oligofructose. Br J Nutr 2002; 87(Suppl. 2): 193–197.
  • Bhowmik D, Dubey J, Mehra S. Probiotic Efficiency of Spirulina platensis – Stimulating Growth of Lactic Acid Bacteria. World J. Dairy & Food Sci 2009; 4(2): 160–163.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.desklight-dbf685f9-3c2e-4d9a-a61c-ed518fce51ca
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.